Physician profile
Naixi N Chen
NPI 1265490312
$32,176.36
in general payments reported to CMS, 2019-2025
95 companies · $6,514 in 2025
The $6,514 reported for 2025 was more than what 84% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,696 · 2020: $912 · 2021: $3,121 · 2022: $5,410 · 2023: $6,043 · 2024: $6,481 · 2025: $6,514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Long Term Medical Supply Or Device Loan: $2,250 · Education: $1,339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,449.06 |
| Long Term Medical Supply Or Device Loan | $2,249.91 |
| Education | $1,338.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,879.92 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $2,266.81 | 2019-2025 | Enhertu, Tagrisso, Lynparza |
| E.R. Squibb & Sons, L.L.C. | $2,059.08 | 2019-2025 | Opdivo, Opdualag, Augtyro |
| Janssen Biotech, INC. | $1,643.98 | 2019-2025 | Erleada, Tecvayli, Darzalex |
| Seagen INC. | $1,367.02 | 2019-2025 | Padcev, Tukysa, Tivdak |
| Abbvie INC. | $1,163.79 | 2021-2025 | Venclexta |
| Genzyme Corporation | $1,115.14 | 2019-2025 | |
| Amgen INC. | $1,106.24 | 2019-2023 | Lumakras, Kyprolis, Blincyto |
| Pfizer INC. | $989.43 | 2019-2025 | |
| Glaxosmithkline, LLC. | $769.28 | 2021-2025 | Zejula, Jemperli, Ojjaara |
| Astellas Pharma US INC | $756.50 | 2019-2025 | Xospata, Vyloy, Padcev |
| Lilly USA, LLC | $755.97 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Celgene Corporation | $741.77 | 2019-2025 | Reblozyl, Pomalyst |
| Merck Sharp & Dohme LLC | $627.31 | 2019-2024 | Keytruda, Lynparza, Dificid |
| Eisai INC. | $609.93 | 2019-2025 |
Show all 95 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $592.60 | 2019-2025 | Jakafi, Monjuvi, Zynyz |
| Genentech USA, INC. | $589.88 | 2019-2025 | Venclexta, Tecentriq, Itovebi |
| Pharmacyclics LLC, An Abbvie Company | $570.24 | 2019-2023 | Imbruvica |
| Bayer Healthcare Pharmaceuticals INC. | $563.78 | 2019-2025 | |
| Tersera Therapeutics LLC | $467.13 | 2021-2025 | Quzyttir, Zoladex, Xermelo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $460.97 | 2019-2025 | Gilotrif |
| Daiichi Sankyo INC. | $445.45 | 2021-2025 | Enhertu, Datroway |
| Array Biopharma INC | $430.12 | 2019-2025 | Braftovi, Lorbrena, Mektovi |
| Beigene USA, INC. | $423.63 | 2021-2025 | Brukinsa, Tevimbra |
| Taiho Oncology, INC. | $409.98 | 2023-2025 | |
| Stemline Therapeutics INC. | $400.89 | 2022-2025 | Orserdu, Elzonris |
| Sobi, INC | $361.49 | 2022-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $358.92 | 2019-2025 | Alunbrig, Iclusig |
| Exelixis INC. | $276.91 | 2019-2024 | Cabometyx |
| Regeneron Healthcare Solutions, INC. | $268.37 | 2022-2025 | Libtayo |
| Octapharma USA, INC. | $249.74 | 2019-2025 | Octagam Immune Globulin (Human) |
| Emd Serono, INC. | $222.55 | 2021-2025 | Bavencio |
| Gilead Sciences, INC. | $220.60 | 2021-2025 | Trodelvy |
| Coherus Oncology, INC. | $216.70 | 2023-2024 | |
| Organon LLC | $210.56 | 2023-2025 | Ontruzant |
| Beone Medicines USA, INC. | $204.12 | 2025 | Brukinsa, Tevimbra |
| Kite Pharma, INC. | $196.23 | 2019-2023 | Yescarta |
| Pharmacosmos Therapeutics INC. | $192.21 | 2022-2025 | Monoferric |
| Foundation Medicine, INC. | $173.73 | 2021-2023 | |
| Ge Healthcare | $160.52 | 2021-2022 | |
| Verastem, INC. | $152.30 | 2019-2025 | Avmapki Fakzynja Co-Pack |
| Jazz Pharmaceuticals INC. | $144.03 | 2021-2025 | |
| Deciphera Pharmaceuticals INC. | $139.88 | 2021-2023 | Qinlock |
| Morphosys, US INC. | $132.76 | 2021-2023 | Monjuvi |
| Mirati Therapeutics, INC. | $131.34 | 2023-2024 | Krazati |
| Aveo Pharmaceuticals, INC. | $129.56 | 2022 | |
| Accord Healthcare, INC. | $110.11 | 2024-2025 | |
| Clovis Oncology, INC. | $107.80 | 2019-2022 | |
| Acrotech Biopharma INC. | $105.44 | 2023-2025 | Beleodaq |
| Alnylam Pharmaceuticals INC. | $104.30 | 2022-2024 | Oxlumo |
| Adc Therapeutics America, INC. | $102.17 | 2024-2025 | |
| Cti Biopharma Corp. | $101.69 | 2022-2023 | Vonjo |
| Puma Biotechnology, INC. | $97.83 | 2019-2023 | |
| Servier Pharmaceuticals LLC | $96.56 | 2022-2024 | |
| Syndax Pharmaceuticals, INC. | $95.57 | 2025 | |
| Blueprint Medicines Corporation | $94.63 | 2021-2023 | Ayvakit |
| Springworks Therapeutics, INC. | $94.55 | 2024-2025 | Ogsiveo |
| Novocure INC. | $93.11 | 2019-2025 | Optune Gio, Optune, Optune Lua (Novottf-200t) |
| Mylan Institutional INC. | $90.41 | 2019-2023 | Ogivri |
| Rigel Pharmaceuticals, INC. | $87.06 | 2019-2025 | Rezlidhia, Gavreto, Tavalisse |
| Ipsen Biopharmaceuticals, INC | $86.72 | 2020-2023 | Onivyde |
| Sun Pharmaceutical Industries INC. | $86.49 | 2022-2023 | Yonsa, Odomzo |
| Amneal Pharmaceuticals LLC | $81.16 | 2022-2024 | Avastin, Neulasta, Neupogen |
| Azurity Pharmaceuticals, INC. | $75.25 | 2025 | Danziten |
| Tesaro, INC. | $68.19 | 2019 | |
| Dendreon Pharmaceuticals LLC | $66.22 | 2025 | Provenge |
| Tempus Ai, INC | $65.56 | 2024 | |
| Recordati_rare_diseases_inc. | $58.10 | 2025 | Enjaymo, Panhematin |
| Epizyme, INC. | $55.32 | 2022-2023 | Tazverik |
| Caris Mpi, INC. | $53.44 | 2025 | Mi Cancer Seek |
| Macrogenics, INC. | $51.38 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $50.15 | 2023-2024 | Orgovyx |
| Sanofi-Aventis U.S. LLC | $46.30 | 2019 | |
| Spectrum Pharmaceuticals INC. | $46.11 | 2024-2025 | Rolvedon |
| Biocon Biologics INC | $44.29 | 2024-2025 | Ogivri |
| Myovant Sciences INC. | $41.42 | 2021 | |
| Digestive Care, INC. | $40.68 | 2023-2025 | Pertzye |
| Pharmaessentia USA Corporation | $39.32 | 2025 | Besremi |
| Adaptive Biotechnologies Corporation | $37.45 | 2025 | Clonoseq |
| Helsinn Therapeutics (U.S.), INC. | $33.08 | 2019-2022 | |
| Sandoz INC. | $27.09 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $26.27 | 2024 | Truxima |
| Partner Therapeutics, INC. | $25.90 | 2024 | Leukine |
| G1 Therapeutics, INC. | $24.39 | 2022 | |
| Tg Therapeutics, INC. | $24.20 | 2022 | |
| Cycle Pharmaceuticals INC | $23.84 | 2025 | Phyrago |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.00 | 2019 | |
| Shire North American Group INC | $20.88 | 2019 | |
| Phathom Pharmaceuticals, INC. | $19.99 | 2024 | Voquezna |
| Geron Corporation | $18.97 | 2025 | Rytelo |
| Apellis Pharmaceuticals, INC. | $18.71 | 2024 | Empaveli |
| Agios Pharmaceuticals, INC. | $18.31 | 2019 | |
| Celltrion USA INC. | $16.80 | 2024 | Vegzelma |
| Pharming Healthcare, INC. | $16.08 | 2023 | Ruconest |
| Ferring Pharmaceuticals INC. | $15.71 | 2019 |
Drugs and devices associated with these payments
Kisqali $2,315Erleada $743Sarclisa $693Enhertu $610Imbruvica $567Opdivo $563Venclexta $488Zejula $424Lonsurf $410Inqovi $410Brukinsa $368Jemperli $362Jaypirca $353Verzenio $353Orserdu $352Lynparza $341Opdualag $334Braftovi $334Lorbrena $304Padcev $303Mektovi $303Tagrisso $287Xalkori $273Tecvayli $258Keytruda $235Libtayo $235Darzalex $224Udenyca $217Vitrakvi $204Balversa $204Stivarga $204Tukysa $202Tevimbra $201Lenvima $200Epkinly $197Reblozyl $190Quzyttir $182Akeega $180Adcetris $180Calquence $180Xtandi $176Ontruzant $176Jakafi $172Xospata $171Monoferric $168Pertzye $163Talvey $163Doptelet $145Gilotrif $142Talzenna $139Zoladex $136Elrexfio $135Nubeqa $132Krazati $131Ojjaara $131Vonjo $127Ibrance $127Monjuvi $115Alunbrig $110Rybrevant $109Beleodaq $105Retevmo $101Vyloy $98.10Orgovyx $97.34Tivdak $95.50Ogsiveo $94.55Inlyta $92.16Zepzelca $88.80Lumakras $87.07Camcevi $85.17Oxlumo $81.01Xofigo $79.95Qinlock $78.37Optune Gio $76.82Pomalyst $75.94Danziten $75.25Rezlidhia $70.60Tavalisse $70.60Faslodex $70.43Kyprolis $67.56Cabometyx $66.97Provenge $66.22Tecentriq $63.82Imfinzi $62.02Ogivri $59.94Tibsovo $59.90Elahere $57.93Neupogen $55.02Neulasta $55.02Avastin $55.02Mekinist $54.13Yonsa $54.03Odomzo $54.03Gavreto $53.76Mi Cancer Seek $53.44Dificid $50.33Shingrix $49.44Emrelis $49.23Rolvedon $46.11Augtyro $45.45
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naixi Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.